T1	Age 2 13	25-year-old
T2	Sex 14 20	female
T3	Disease_disorder 52 63	visual loss
E1	Disease_disorder:T3 
T4	Detailed_description 41 51	left-sided
R1	MODIFY Arg1:T4 Arg2:E1	
T5	Disease_disorder 68 78	amenorrhea
E2	Disease_disorder:T5 
T6	Date 79 92	2 years prior
E3	Date:T6 
T7	Disease_disorder 119 130	hemiparesis
E4	Disease_disorder:T7 
T8	Detailed_description 113 118	right
R2	MODIFY Arg1:T8 Arg2:E4	
T9	Date 142 161	6 months beforehand
E5	Date:T9 
T10	Sign_symptom 174 182	symptoms
E6	Sign_symptom:T10 
T11	Severity 163 173	Aggravated
R3	MODIFY Arg1:T11 Arg2:E6	
T12	Sign_symptom 184 192	drooping
E7	Sign_symptom:T12 
T13	Biological_structure 196 215	corner of right lip
R4	MODIFY Arg1:T13 Arg2:E7	
T14	Disease_disorder 239 249	hemianopia
E8	Disease_disorder:T14 
T15	Detailed_description 230 238	temporal
T16	Detailed_description 220 229	bilateral
R5	MODIFY Arg1:T15 Arg2:E8	
R6	MODIFY Arg1:T16 Arg2:E8	
T17	Clinical_event 268 283	hospitalization
E9	Clinical_event:T17 
T18	Distance 310 315	>5 cm
T19	Severity 301 308	massive
T20	Sign_symptom 317 322	tumor
E10	Sign_symptom:T20 
T21	Biological_structure 326 357	intra- and suprasellar location
R7	MODIFY Arg1:T21 Arg2:E10	
T22	Detailed_description 359 391	excluding mesencephalon backward
R8	MODIFY Arg1:T22 Arg2:E10	
R9	MODIFY Arg1:T18 Arg2:E10	
R10	MODIFY Arg1:T19 Arg2:E10	
T23	Diagnostic_procedure 405 428	computerized tomography
E11	Diagnostic_procedure:T23 
T24	Diagnostic_procedure 430 432	CT
E12	Diagnostic_procedure:T24 
T25	Biological_structure 441 445	head
R11	MODIFY Arg1:T25 Arg2:E11	
R12	IDENTICAL Arg1:E12 Arg2:E11	
T26	Diagnostic_procedure 516 525	prolactin
E13	Diagnostic_procedure:T26 
T27	Diagnostic_procedure 527 530	PRL
E14	Diagnostic_procedure:T27 
R13	IDENTICAL Arg1:E14 Arg2:E13	
T28	Lab_value 484 500	exceedingly high
R14	MODIFY Arg1:T28 Arg2:E13	
T29	Biological_structure 501 506	serum
R15	MODIFY Arg1:T29 Arg2:E13	
T30	Lab_value 533 543	4408 ng/ml
R16	MODIFY Arg1:T30 Arg2:E13	
T31	Diagnostic_procedure 568 592	other pituitary hormones
E15	Diagnostic_procedure:T31 
T32	Lab_value 598 621	within reference ranges
R17	MODIFY Arg1:T32 Arg2:E15	
T33	Diagnostic_procedure 622 637	(growth hormone
E16	Diagnostic_procedure:T33 
T34	Diagnostic_procedure 639 641	GH
E17	Diagnostic_procedure:T34 
R18	IDENTICAL Arg1:E17 Arg2:E16	
R19	SUB_PROCEDURE Arg1:E16 Arg2:E15	
T35	Lab_value 644 654	0.50 ng/ml
R20	MODIFY Arg1:T35 Arg2:E16	
T36	Diagnostic_procedure 656 675	luteinizing hormone
E18	Diagnostic_procedure:T36 
T37	Diagnostic_procedure 677 679	LH
E19	Diagnostic_procedure:T37 
R21	IDENTICAL Arg1:E19 Arg2:E18	
T38	Lab_value 682 693	2.60 mIU/ml
R22	MODIFY Arg1:T38 Arg2:E18	
T39	Diagnostic_procedure 695 723	follicle-stimulating hormone
E20	Diagnostic_procedure:T39 
T40	Diagnostic_procedure 725 728	FSH
E21	Diagnostic_procedure:T40 
R23	IDENTICAL Arg1:E21 Arg2:E20	
T41	Diagnostic_procedure 744 771	adrenocorticotropic hormone
E22	Diagnostic_procedure:T41 
T42	Diagnostic_procedure 773 777	ACTH
E23	Diagnostic_procedure:T42 
R24	IDENTICAL Arg1:E23 Arg2:E22	
T43	Lab_value 780 790	37.4 pg/ml
R25	MODIFY Arg1:T43 Arg2:E22	
T44	Lab_value 731 742	4.57 mIU/ml
R26	MODIFY Arg1:T44 Arg2:E20	
T45	Diagnostic_procedure 792 819	thyroid-stimulating hormone
E24	Diagnostic_procedure:T45 
T46	Diagnostic_procedure 821 824	TSH
E25	Diagnostic_procedure:T46 
R27	IDENTICAL Arg1:E25 Arg2:E24	
T47	Lab_value 827 838	2.68 μIU/ml
R28	MODIFY Arg1:T47 Arg2:E24	
T48	Detailed_description 841 852	T1-weighted
T49	Diagnostic_procedure 853 871	magnetic resonance
E26	Diagnostic_procedure:T49 
T50	Diagnostic_procedure 873 875	MR
E27	Diagnostic_procedure:T50 
R29	IDENTICAL Arg1:E27 Arg2:E26	
R30	MODIFY Arg1:T48 Arg2:E26	
T51	Detailed_description 890 898	contrast
T52	Detailed_description 900 910	gadolinium
R31	MODIFY Arg1:T52 Arg2:T51	
R32	MODIFY Arg1:T51 Arg2:E26	
T53	Sign_symptom 931 936	tumor
E28	Sign_symptom:T53 
T54	Detailed_description 919 930	homogeneous
R33	MODIFY Arg1:T54 Arg2:E28	
T56	Sign_symptom 978 987	edematous
E30	Sign_symptom:T56 
T57	Diagnostic_procedure 991 1008	T2-weighted views
E31	Diagnostic_procedure:T57 
R35	SUB_PROCEDURE Arg1:E31 Arg2:E26	
A1	POLARITY E30 NEG
T58	Biological_structure 954 969	adjacent tissue
R36	MODIFY Arg1:T58 Arg2:E30	
R37	MODIFY Arg1:T58 Arg2:E31	
T59	Sign_symptom 1014 1018	mass
E32	Sign_symptom:T59 
T60	Sign_symptom 1027 1034	regress
E33	Sign_symptom:T60 
A2	POLARITY E33 NEG
T61	Duration 1046 1052	4-week
E34	Duration:T61 
T62	Medication 1067 1082	dopamine analog
E35	Medication:T62 
T63	Medication 1084 1095	cabergoline
E36	Medication:T63 
T64	Dosage 1097 1106	1 mg/week
R38	MODIFY Arg1:T64 Arg2:E36	
R39	SUB_PROCEDURE Arg1:E36 Arg2:E35	
T65	Diagnostic_procedure 1119 1122	PRL
E37	Diagnostic_procedure:T65 
T66	Biological_structure 1113 1118	serum
R40	MODIFY Arg1:T66 Arg2:E37	
T67	Lab_value 1130 1140	2207 ng/ml
T68	Lab_value 1151 1159	elevated
R41	MODIFY Arg1:T67 Arg2:E37	
R42	MODIFY Arg1:T68 Arg2:E37	
T69	Sign_symptom 1231 1239	enlarged
E38	Sign_symptom:T69 
T70	Severity 1240 1248	somewhat
R43	MODIFY Arg1:T70 Arg2:E38	
T71	Biological_structure 1198 1221	right lateral ventricle
R44	MODIFY Arg1:T71 Arg2:E38	
T72	Sign_symptom 1257 1268	obstruction
E39	Sign_symptom:T72 
T73	Biological_structure 1272 1288	foramen of Monro
R45	MODIFY Arg1:T73 Arg2:E39	
R46	CAUSE Arg1:E39 Arg2:E38	
T74	Therapeutic_procedure 1340 1349	debulking
E40	Therapeutic_procedure:T74 
T75	Detailed_description 1331 1339	surgical
R47	MODIFY Arg1:T75 Arg2:E40	
T76	Therapeutic_procedure 1386 1396	craniotomy
E41	Therapeutic_procedure:T76 
T77	Therapeutic_procedure 1410 1434	transsphenoidal approach
E42	Therapeutic_procedure:T77 
R48	SUB_PROCEDURE Arg1:E41 Arg2:E40	
R49	SUB_PROCEDURE Arg1:E42 Arg2:E40	
T78	Sign_symptom 1472 1477	tumor
E43	Sign_symptom:T78 
T79	Texture 1440 1456	hardened elastic
R50	MODIFY Arg1:T79 Arg2:E43	
T80	Sign_symptom 1493 1504	attachments
E44	Sign_symptom:T80 
T81	Severity 1486 1492	strong
R51	MODIFY Arg1:T81 Arg2:E44	
T82	Biological_structure 1508 1530	neighboring structures
R52	MODIFY Arg1:T82 Arg2:E44	
T83	Therapeutic_procedure 1541 1557	complete removal
E45	Therapeutic_procedure:T83 
A3	POLARITY E45 NEG
T84	Sign_symptom 1571 1582	mass effect
E46	Sign_symptom:T84 
A4	TREND E46 DEC
T85	Diagnostic_procedure 1619 1622	PRL
E47	Diagnostic_procedure:T85 
T86	Biological_structure 1613 1618	serum
R53	MODIFY Arg1:T86 Arg2:E47	
T87	Lab_value 1629 1637	declined
T88	Lab_value 1642 1651	250 ng/ml
R54	MODIFY Arg1:T87 Arg2:E47	
R55	MODIFY Arg1:T88 Arg2:E47	
T89	Diagnostic_procedure 1713 1716	PRL
E48	Diagnostic_procedure:T89 
T90	Medication 1772 1783	cabergoline
E49	Medication:T90 
T91	Dosage 1800 1810	0.5 mg/day
R56	MODIFY Arg1:T91 Arg2:E49	
T92	Lab_value 1696 1709	normalization
R57	MODIFY Arg1:T92 Arg2:E48	
T93	Sign_symptom 1853 1861	regrowth
E50	Sign_symptom:T93 
A5	POLARITY E50 NEG
T94	Sign_symptom 1873 1883	metastasis
E51	Sign_symptom:T94 
A6	POLARITY E51 NEG
T95	Detailed_description 1865 1872	distant
R58	MODIFY Arg1:T95 Arg2:E51	
T96	Date 1884 1896	1 year after
E52	Date:T96 
T97	Diagnostic_procedure 1906 1925	Histopathologically
E53	Diagnostic_procedure:T97 
T98	Diagnostic_procedure 1927 1948	hematoxylin and eosin
E54	Diagnostic_procedure:T98 
T99	Diagnostic_procedure 1950 1953	H&E
E55	Diagnostic_procedure:T99 
R59	IDENTICAL Arg1:E55 Arg2:E54	
R60	SUB_PROCEDURE Arg1:E54 Arg2:E53	
T100	Diagnostic_procedure 2141 2150	cytoplasm
E56	Diagnostic_procedure:T100 
T101	Diagnostic_procedure 2117 2123	nuclei
E57	Diagnostic_procedure:T101 
T102	Lab_value 2128 2140	eosinophilic
T103	Shape 2107 2116	elongated
T104	Shape 2098 2102	oval
T105	Shape 2091 2096	round
T106	Sign_symptom 2072 2085	spindle cells
E58	Sign_symptom:T106 
T107	Biological_structure 1975 1984	specimens
R61	MODIFY Arg1:T107 Arg2:E54	
T108	Detailed_description 2058 2067	polygonal
R62	MODIFY Arg1:T108 Arg2:E58	
R63	MODIFY Arg1:T105 Arg2:E57	
R64	MODIFY Arg1:T104 Arg2:E57	
R65	MODIFY Arg1:T103 Arg2:E57	
R66	MODIFY Arg1:T102 Arg2:E56	
R67	MODIFY Arg1:E58 Arg2:E57	
R68	MODIFY Arg1:E58 Arg2:E56	
R69	SUB_PROCEDURE Arg1:E57 Arg2:E54	
R70	SUB_PROCEDURE Arg1:E56 Arg2:E54	
T109	Coreference 2167 2172	cells
E59	Coreference:T109 
R71	IDENTICAL Arg1:E59 Arg2:E58	
T110	Detailed_description 2180 2195	irregular nests
T111	Detailed_description 2199 2214	short fascicles
T112	Detailed_description 2231 2287	frequent hyaline changes in vessel walls and vacuolation
R72	MODIFY Arg1:T110 Arg2:E59	
R73	MODIFY Arg1:T111 Arg2:E59	
R74	MODIFY Arg1:T112 Arg2:E59	
T113	Sign_symptom 2303 2323	nuclear pleomorphism
E60	Sign_symptom:T113 
T114	Sign_symptom 2368 2385	high mitotic rate
E61	Sign_symptom:T114 
A7	POLARITY E61 NEG
T115	Sign_symptom 2390 2398	necrosis
E62	Sign_symptom:T115 
A8	POLARITY E62 NEG
T116	Sign_symptom 2436 2450	fibrous change
E63	Sign_symptom:T116 
T117	Biological_structure 2454 2466	tumor stroma
R75	MODIFY Arg1:T117 Arg2:E63	
T118	Diagnostic_procedure 2559 2588	Pearse’s Periodic Acid Schiff
E64	Diagnostic_procedure:T118 
T119	Diagnostic_procedure 2590 2593	PAS
E65	Diagnostic_procedure:T119 
R76	IDENTICAL Arg1:E65 Arg2:E64	
T120	Biological_structure 2530 2541	tumor cells
R77	MODIFY Arg1:T120 Arg2:E64	
T121	Lab_value 2507 2519	chromophobic
R78	MODIFY Arg1:T121 Arg2:E64	
T122	Diagnostic_procedure 2611 2623	Immunostains
E66	Diagnostic_procedure:T122 
T123	Diagnostic_procedure 2661 2664	PRL
E67	Diagnostic_procedure:T123 
T124	Diagnostic_procedure 2675 2689	chromogranin-A
E68	Diagnostic_procedure:T124 
T125	Diagnostic_procedure 2695 2708	synaptophysin
E69	Diagnostic_procedure:T125 
R79	SUB_PROCEDURE Arg1:E67 Arg2:E66	
R80	SUB_PROCEDURE Arg1:E68 Arg2:E66	
R81	SUB_PROCEDURE Arg1:E69 Arg2:E66	
T126	Lab_value 2646 2656	positivity
R82	MODIFY Arg1:T126 Arg2:E67	
R83	MODIFY Arg1:T126 Arg2:E68	
R84	MODIFY Arg1:T126 Arg2:E69	
T127	Diagnostic_procedure 2713 2727	other hormones
E70	Diagnostic_procedure:T127 
T128	Diagnostic_procedure 2729 2731	GH
E71	Diagnostic_procedure:T128 
T129	Diagnostic_procedure 2733 2736	TSH
E72	Diagnostic_procedure:T129 
T130	Diagnostic_procedure 2738 2742	ACTH
E73	Diagnostic_procedure:T130 
T131	Diagnostic_procedure 2744 2746	LH
E74	Diagnostic_procedure:T131 
T132	Diagnostic_procedure 2748 2751	FSH
E75	Diagnostic_procedure:T132 
R85	SUB_PROCEDURE Arg1:E71 Arg2:E70	
R86	SUB_PROCEDURE Arg1:E72 Arg2:E70	
R87	SUB_PROCEDURE Arg1:E73 Arg2:E70	
R88	SUB_PROCEDURE Arg1:E74 Arg2:E70	
R89	SUB_PROCEDURE Arg1:E75 Arg2:E70	
T133	Lab_value 2710 2712	No
R90	MODIFY Arg1:T133 Arg2:E70	
T134	Diagnostic_procedure 2792 2805	other markers
E76	Diagnostic_procedure:T134 
T135	Lab_value 2986 2994	negative
T136	Diagnostic_procedure 2817 2830	S-100 protein
E77	Diagnostic_procedure:T136 
T137	Diagnostic_procedure 2841 2872	glial fibrillary acidic protein
E78	Diagnostic_procedure:T137 
T138	Diagnostic_procedure 2874 2878	GFAP
E79	Diagnostic_procedure:T138 
R92	IDENTICAL Arg1:E79 Arg2:E78	
T139	Diagnostic_procedure 2881 2908	epithelial membrane antigen
E80	Diagnostic_procedure:T139 
T140	Diagnostic_procedure 2910 2913	EMA
E81	Diagnostic_procedure:T140 
R93	IDENTICAL Arg1:E81 Arg2:E80	
T141	Diagnostic_procedure 2916 2935	cytokeratin AE1/AE3
E82	Diagnostic_procedure:T141 
T142	Diagnostic_procedure 2937 2947	CK AE1/AE3
E83	Diagnostic_procedure:T142 
R94	IDENTICAL Arg1:E83 Arg2:E82	
T143	Diagnostic_procedure 2950 2958	vimentin
E84	Diagnostic_procedure:T143 
T144	Diagnostic_procedure 2960 2963	p53
E85	Diagnostic_procedure:T144 
T145	Diagnostic_procedure 2969 2974	bcl-2
E86	Diagnostic_procedure:T145 
R95	BEFORE Arg1:E77 Arg2:E76	
R96	BEFORE Arg1:E78 Arg2:E76	
R97	SUB_PROCEDURE Arg1:E80 Arg2:E76	
R98	SUB_PROCEDURE Arg1:E82 Arg2:E76	
R99	SUB_PROCEDURE Arg1:E84 Arg2:E76	
R100	SUB_PROCEDURE Arg1:E85 Arg2:E76	
R91	SUB_PROCEDURE Arg1:E86 Arg2:E76	
R101	MODIFY Arg1:T135 Arg2:E76	
T146	Diagnostic_procedure 3014 3034	Ki-67 labeling index
E87	Diagnostic_procedure:T146 
T147	Lab_value 3053 3056	2 %
R102	MODIFY Arg1:T147 Arg2:E87	
T148	Disease_disorder 3093 3110	pituitary adenoma
E88	Disease_disorder:T148 
T149	Detailed_description 3079 3092	PRL-producing
R103	MODIFY Arg1:T149 Arg2:E88	
*	OVERLAP E1 E2 E3
T150	Clinical_event 102 106	seen
E89	Clinical_event:T150 
R104	BEFORE Arg1:E3 Arg2:E89	
R105	AFTER Arg1:E89 Arg2:E4	
*	OVERLAP E4 E5
R106	BEFORE Arg1:E5 Arg2:E6	
*	OVERLAP E6 E7 E8
R107	BEFORE Arg1:E8 Arg2:E9	
*	OVERLAP E9 E10 E11 E13 E15 E26 E28 E30
R108	SUB_PROCEDURE Arg1:E18 Arg2:E15	
R109	SUB_PROCEDURE Arg1:E20 Arg2:E15	
R110	SUB_PROCEDURE Arg1:E22 Arg2:E15	
R111	SUB_PROCEDURE Arg1:E24 Arg2:E15	
T55	Detailed_description 937 948	enhancement
R34	MODIFY Arg1:T55 Arg2:E28	
R112	BEFORE Arg1:E30 Arg2:E32	
*	OVERLAP E32 E33 E34 E35 E37 E38 E39
R113	MODIFY Arg1:E34 Arg2:E35	
R114	BEFORE Arg1:E39 Arg2:E40	
*	OVERLAP E40 E43 E44 E45
R115	BEFORE Arg1:E45 Arg2:E46	
*	OVERLAP E46 E47 E48 E49
R116	BEFORE Arg1:E49 Arg2:E50	
*	OVERLAP E50 E51 E52
R117	AFTER Arg1:E52 Arg2:E53	
*	OVERLAP E58 E59 E60 E61 E62 E63 E64 E66 E70 E76 E87 E88
